Camden National Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Hold
452
0.03% 168
2026
Q1
$254K Hold
452
0.03% 142
2025
Q4
$306K Buy
452
+5
+1% +$3.4K 0.04% 130
2025
Q3
$286K Hold
447
0.04% 134
2025
Q2
$240K Buy
+447
New +$214K 0.03% 150
2024
Q4
Sell
-447
Closed -$226K 172
2024
Q3
$226K Sell
447
-243
-35% -$118K 0.03% 155
2024
Q2
$336K Hold
690
0.05% 106
2024
Q1
$373K Sell
690
-118
-15% -$64.5K 0.07% 100
2023
Q4
$448K Sell
808
-25
-3% -$11.7K 0.08% 86
2023
Q3
$364K Buy
833
+250
+43% +$125K 0.07% 92
2023
Q2
$293K Buy
583
+28
+5% +$13.4K 0.06% 104
2023
Q1
$278K Sell
555
-5
-0.9% -$2.39K 0.06% 104
2022
Q4
$228K Buy
+560
New +$217K 0.05% 114
2022
Q2
Sell
-590
Closed -$323K 132
2022
Q1
$323K Sell
590
-19
-3% -$9.99K 0.06% 114
2021
Q4
$401K Hold
609
0.07% 109
2021
Q3
$379K Sell
609
-15
-2% -$10.1K 0.07% 102
2021
Q2
$394K Sell
624
-431
-41% -$238K 0.07% 103
2021
Q1
$516K Sell
1,055
-30
-3% -$15K 0.1% 91
2020
Q4
$542K Sell
1,085
-304
-22% -$136K 0.11% 87
2020
Q3
$546K Buy
1,389
+105
+8% +$38.8K 0.12% 85
2020
Q2
$424K Buy
1,284
+17
+1% +$4.92K 0.11% 88
2020
Q1
$307K Buy
1,267
+137
+12% +$35.8K 0.08% 95
2019
Q4
$295K Sell
1,130
-14
-1% -$3.69K 0.06% 107
2019
Q3
$311K Buy
1,144
+414
+57% +$115K 0.07% 99
2019
Q2
$201K Buy
+730
New +$180K 0.05% 114

Other funds holding IDXX

Camden National Bank's IDXX Position: Q2 2026 in Review

Camden National Bank held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 452 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #168.

Camden National Bank first reported a position in IDXX in Q2 2019 and has held it in 25 quarters since. The position peaked at $546K in Q3 2020. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Camden National Bank held 452 shares of Idexx Laboratories worth $238K as of Q2 2026.
  • Camden National Bank left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.03% of Camden National Bank's portfolio in Q2 2026, its #168 holding.
  • Camden National Bank first reported a position in Idexx Laboratories in Q2 2019 and has held it in 25 quarters since.
  • Camden National Bank's Idexx Laboratories position peaked at $546K in Q3 2020.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Camden National Bank's 13F filing for Q2 2026, filed 31 Jul 2026.